中文
Earlier issues
Announcement
More
Progress in Chemistry 2015, Vol. 27 Issue (9): 1260-1274 DOI: 10.7536/PC150203 Previous Articles   Next Articles

• Review and comments •

Conformational Restriction of Peptidomimetics in Drug Design

Hou hui, Sun Dequn*   

  1. Marine College, Shandong University at Weihai, Weihai 264209, China
  • Received: Revised: Online: Published:
PDF ( 1869 ) Cited
Export

EndNote

Ris

BibTeX

Peptidomimetics are important drug design tools as substitutes for peptides in active sites of enzymes and receptors. The incorporation of some specific structure into biologically active peptides may lead to conformationally restricted peptidomimetics. Conformational restriction of peptidomimetics may significantly improve the pharmacodynamic properties and pharmacokinetic properties, including bioactivity, selectivity to receptors, stability of metabolism and absorption properties. To develop new approaches, allow rational design and synthesis of restricted peptidomimetics is of importance. Herein, we review two approaches to access conformationally restricted peptidomimetics, the local conformational restriction approach and the overall cyclization approach.

Contents
1 Introduction
2 Local conformational restriction of peptide
2.1 Cα-methylated amino acids
2.2 N-methylated amino acids
2.3 Cα,Cα-dialkyl amino acids
2.4 Cβ,Cβ-dialkyl amino acids
2.5 α,β-unsaturated amino acids
2.6 C-C cyclization of amino acids
2.7 C-N cyclization of amino acids
2.8 N-N cyclization of amino acids
3 The overall cyclization of peptides
3.1 The overall cyclization methods of peptides
3.2 Other cyclization methods expect lactam bond
4 Conclusion

Key words: drug design, peptidomimetics, conformational restriction, bioactivity, metabolic stability

CLC Number: 

[1] Vlieghe P, Lisowski V, Martinez J, Khrestchatisky M. Drug Discovery Today, 2010, 15(1/2): 40.
[2] Craik D J, Fairlie D P, Liras S. Chem. Biol. Drug Des., 2013, 81(1): 136.
[3] Wood M P, Cole1 A L, Ruchala P, Waring A J, Rohan L C, Marx P, Tarwater P M, Gupta P, Cole A M. PLoS One, 2013, 8(2): 1.
[4] Crisma M, Formaggio F, Toniolo C, Yoshikawa T, Wakamiya T. J. Am. Chem. Soc., 1999, 121: 3272.
[5] Pirat C, Farce A, Lebègue N, Renault N, Furman C, Millet R, Yous S, Speca S, Berthelot P. J. Med. Chem., 2012, 55: 4027.
[6] Olson G L, Bolin D R, Bonner M P. J. Med. Chem., 1993, 36: 3039.
[7] Mills F D, Antharam V C, Ganesh O K, Elliott D W, McNeill S A, Long J R. Biochemistry, 2008, 47: 8292.
[8] Demirev P A. Anal. Chem., 2013, 85: 779.
[9] Chang L C, Yang C Y, Chu A C N, Lin Y J, Lai S M. Pharmaceutics, 2011, 8: 1767.
[10] Han J, Sun L D, Chu Y Y, Li Z, Huang D D, Zhu X Y. J. Med. Chem., 2013, 56: 9955.
[11] Bausch D, Thomas S, Mino-Kenudson M, Castillo C F, Bauer T W, Williams M, Warshaw A L, Thayer S P, Kelly K A. Clin. Cancer Res., 2011, 17(2): 302.
[12] Jung K H, Angela H S, Stanley A T. Molecular pharmacology, 2011, 80(3): 357.
[13] 周家驹(Zhou J J), 雷静(Lei J), 谢桂荣(Xie G R). 化学进展(Progress in Chemistry), 2000, 12(2/3): 332.
[14] Karle Z L, Flppen-Anderson J L, Uma K, Balaram P. Biopolymers, 1990, 29(14): 1835.
[15] Toniolo C, Crisma M, Formaggio F, Valle C, Cavicchioni G, Precigoux G, Aubry A, Kamphuis J. Biopolymers, 1993, 33 (7): 1061.
[16] Dehner A, Planker E, Gemmecker G, Broxterman Q B, Bisson W, Formaggio F, Crisma M, Toniolo C, Kessler H. J. Am. Chem. Soc., 2001, 123: 6678.
[17] Dechantsreiter M A, Planker E, Matha B, Lohof E, Kessler H. J. Med. Chem., 1999, 42: 3033.
[18] Chatterjee J, Ovadia O, Zahn G, Marinelli L, Hoffman A, Gilon C, Kessler H. J. Med. Chem., 2007, 50: 5878.
[19] Nowick S S. Acc. Chem.Res., 2008, 41: 1319.
[20] Formaggio F, Crisma M, Toniolo C. Macromolecules, 2003, 36: 8164.
[21] Evans M C, Pradhan A, Venkatraman S, Ojala W H, Gleason W B, Mishra R K, Johnson R L. J. Med. Chem., 1999, 42: 1441.
[22] Kruszynski M, Lammek B, Manning M. J. Med. Chem., 1980, 23: 364.
[23] Baldisserotto A, Ferretti V, Destro F, Franceschini C, Marastoni M, Gavioli R, Tomatis R. J. Med. Chem., 2010, 53: 6511.
[24] Subasinghe N, Schulte M, Chan M Y M, Roon R J, Koerner J F, Johnsony R L. J. Med. Chem., 1990, 33: 2734.
[25] Cativiela C, Fraile J M, Mayoral J A. Bull. Chem. Soc. Jpn., 1990, 63(8): 2456.
[26] Jimenez A I, Cativiela C, Marraud M. Tetrahedron, 2000, 5353.
[27] 张刘生(Zhang L S), 潘成学(Pan C X). 广西师范大学学报(Journal of Guangxi Normal University), 2011, 29(3): 37.
[28] Naiema M, Julien D, Bruno C, Laurence V B, Nicole B Sandrine O, Fariza R, Michele R R, Sames S. J. Med. Chem., 2004, 47: 6392.
[29] Martin S F, Dorsey G O, Gane T, Hillier M C. J. Med. Chem., 1998, 41: 1581.
[30] Schiller P W, Weltrowska G, Nguyen T M D, Lemieux C, Chung N N, Marsden B J, Wilkes B C. J. Med. Chem., 1991, 34: 3125.
[31] Yamazaki T, Zhu Y F, Probstl A, Chadha R K, Goodman M. J. Org. Chem., 1991, 56: 6644.
[32] Kyle D J, Hicks R P, Blake P R, Klimkowski V J. Inflammatory Disease and Therapy,1990, 5: 131.
[33] Kyle D J, Martin J A, Burch R M, Carter J P, Lu S F, Meeker S, Prosser J C, Sullivan J P, Togo J. J. Med. Chem., 1991, 34: 2649.
[34] Ji H T, Gomez-Vidal J A, Martasek P, Roman L J, Silverman R B. J. Med. Chem., 2006, 49: 6254.
[35] Fulda S, Wick W, Weller M, Debati K M. Nat. Med., 2002, 8: 808.
[36] Arn C R, Chiorean M V, Heldebrant M P, Gores G J, Kaufmann S H. J. Biol. Chem., 2002, 277: 44236.
[37] Yang L, Mashima T, Sato S, Mochizuki M, Sakamoto H, Yamori T, Oh-Hara T, Tsuruo T. Cancer Res., 2003, 63: 831.
[38] Sun H Y, Nikolovska-Coleska Z, Yang C Y, Xu L, Liu M L, Tomita Y, Pan H G, Yoshioka Y,Krajewski K, Roller P P, Wang S M. J. Am. Chem. Soc., 2004, 126: 16686.
[39] Sun H Y, Lu J F, Liu L, Yang C Y, Wang S M. ACS Chem. Biol., 2014, 9: 994.
[40] Mandal P K, Gao F Q, Lu Z, Ren Z Y, Ramesh R, Birtwistle J S, Kaluarachchi K K, Chen X M, Liao W S, McMurray J S. J. Med. Chem., 2011, 54: 3549.
[41] Miller S M, Simon R J, Ng S, Zuckermann R N, Kerr J M, Moos W H. Drug Develop. Res., 1995, 35(1): 20.
[42] Suwai S, Kodadek T. Org. Biomol. Chem., 2013, 11: 2088.
[43] Ventosa-Andrés P, Hradilova L , Krch Dň ák V. ACS Comb. Sci., 2014, 16: 359.
[44] Dubbelboer I R, Lilienberg E, Hedeland M, Bondesson U, Piquette-Miller M. Mol. Pharmaceutics, 2014, 11: 1301.
[45] Grotenbreg G M, Kronemeijer M, Timmer M S M, Oualid F E, Verdoes M, Spalburg E. J. Org. Chem., 2004, 69: 7851.
[46] Cardenas F, Thormann M, Feliz M, Caba J M, Lloyd-WillIams P, Giralt E. J. Org. Chem., 2001, 66: 4580.
[47] Dimaio J, Nguyen T M D, Lenieux C. J. Med. Chem., 1982, 25: 1432.
[48] Mosberg H I, Hurst R, Hruby V J. Life Sci., 1983, 32: 2565.
[49] Nam N H, Ye G F, Sun G Q, Parang K. J.Med.Chem., 2004, 47: 3131.
[50] Mendel S J. Clin. Cancer Res., 1997, 3(12): 2703.
[51] Sleuijfer S, Coquard R I, Papai Z J. Clin. Oncol., 2009, 27(19): 3126.
[52] Chamrád I, Rix U, Stukalov A, Gridling M, Parapatics K, Müller A, Altiok S, Colinge J, Superti-Furga G, Haura E B, Bennett K L. J. Proteome Res., 2013, 12: 4005.
[53] Schiller P W.Peptides, 1984, 6: 219.
[54] Wynants C, Bernd M, Kogler H. Tetrahedron, 1988, 44(3): 941.
[55] Figliozzi G M, Goldsmith R, Banville S C. Methods in Enzymology, 1996, 267: 437.
[56] Patch J A, Barron A E. J. Am. Chem. Soc., 2005, 25: 12092.
[57] Shin S B Y, Yoo B, Todaro L J, Kirshenbaum K. J. Am. Chem. Soc., 2007, 129(11): 3218.
[58] Dutton F E, Lee B H, Johnson S S, Coscarelli E M, Lee P H. J. Med. Chem., 2003, 46: 2057.
[59] Montero A, Beierle J M, Olsen C A, Ghadiri M R. J. Am. Chem.Soc., 2009, 131: 3033.
[60] Tahoori F, Balalaie S, Sheikhnejad R, Sadjadi M, Boloori P. Amino Acid, 2014, 46(4): 1033.
[61] Gerona-Navarro G, Yoel-Rodríguez, Mujtaba S, Frasca A, Patel J, Zeng L, Plotnikov A N, Osman R, Zhou M M. J. Am. Chem. Soc., 2011, 133: 2040.
[62] Yurek-George A, Cecil A R L, Mo A H K, Wen S J, Rogers H, Habens F,Maeda S, Yoshida M, Packham G, Ganesan A. J. Med. Chem., 2007, 50: 5720.
[63] Almeida A M, Li R, Gellman S H. J. Am. Chem. Soc., 2012, 134: 75.
[64] Johannesson P, Lindeberg G, Tong W M, Gogoll A, Synnergren B, Nyberg F, Karlen A, Hallberg A. J. Med. Chem., 1999, 42: 4524.
[65] Bailey K L, Molinski T F. J. Org. Chem., 1999, 64: 2500.
[66] Kase H, Kaneko M, Yamada K. J. Antibiot., 1987, 40: 450.
[67] Sano S, Ikai K, Kuroda H, Nakamura T, Obayashi A, Ezure Y, Enomoto H. J. Antibiot., 1986, 39: 1674.
[68] Pessah I N, Molinski T F, Meloy T D, Wong P, Buck E D, Allen P D, Mohr F C, Mack M M. Am. J. Physiol., 1997, 41: C601.
[69] Johannesson P, Lindeberg G, Johansson A, Nikiforovich G V, Gogoll A, Synnergren B, Greves M L, Nyberg F, Kerlen A, Hallerg A. J. Med. Chem., 2002, 45: 1767.
[70] Light A. Proteins, Structure and Function. Englewood Cliffs NJ:Prentice-Hall Inc. 1975.
[71] Murugavel R, Choudhury A, Walawalkar M G, Pothiraja R, Rao C N R. Chem. Rev., 2008, 108: 3549.
[72] Michele G, Raphaeel D. WO 2012123928 A1 20120920, 2012.
[73] Van Oijen A H, Erkelens C, van Boom J H, Liskamp R M J. J. Am. Chem. Soc., 1989, 111: 9103.
[74] Wu Y L, Kohn J. J. Am. Chem. Soc., 1991, 113: 687.
[75] Davies J S, Tremeer E J. J. Chem. Soc., 1987, 5: 1099.
[76] Thairivongs S, Blinn R J, Pal D T. J. Med. Chem.,1991, 34: 1276.
[77] Robinson J A. Acc. Chem.Res., 2008, 41: 1278.
[78] Patgiri A, Jochim A L, Arora P S. Acc. Chem. Res. 2008, 41: 1289.
[79] Bernal F, Tyler A F, Korsmeyer S J, Walensky L D, Verdine G L. J. Am. Chem. Soc., 2007, 129: 2456.
[80] Walensky L D, Bird G H. J. Med. Chem., 2014, 57: 6275.
[81] Bird G H, Gavathiotis E, LaBelle J L, Katz S G, Walensky L D. ACS Chem. Biol., 2014, 9: 831.
[82] Spokoyny A M, Zou Y K, Ling J J,Yu H T, Lin Y S, Pentelute B L. J. Am. Chem. Soc., 2013, 135: 5946.
[83] Brown S P, Smith A B. J. Am. Chem. Soc., 2015, 137: 4034.
[1] Tong Wang, Wenjiao Zhao, Liangchun Li, Renlin Zheng, Dequn Sun. Synthesis of Dehydroamino Acids and Their Applications in the Drug Research and Development [J]. Progress in Chemistry, 2020, 32(1): 55-71.
[2] Lvhua Liu, Yanyan Zheng*, Lifang Zhang, Chengdong Xiong. Bioactive Polyetheretherketone Implant Composites for Hard Tissue [J]. Progress in Chemistry, 2017, 29(4): 450-458.
[3] Zhan Peng, Wang Xueshun, Liu Xinyong. Contemporary Molecular Targeted Drug in the Context of “Precision Medicine”: An Attempting Discussion of “Precision Drug Design” [J]. Progress in Chemistry, 2016, 28(9): 1363-1386.
[4] Yuan Shuo, Sun Dequn. The Conformational Restriction of β-Peptidomimetics in Drug Design [J]. Progress in Chemistry, 2016, 28(7): 1084-1098.
[5] Ren Yanrong, Tian Feifei, Zhou Peng. Computational Peptidology [J]. Progress in Chemistry, 2012, (9): 1674-1682.
[6] . "Click Chemistry" and Its Growing Applications in Biomedical Field [J]. Progress in Chemistry, 2010, 22(0203): 417-426.
[7]

Ding Shanshan1 Cui Yuanlu1 Gong Zheng2 Yin Yuji2** Yao Kangde2

. Heparin for Growth Factor Delivery systems [J]. Progress in Chemistry, 2008, 20(12): 1998-2011.
[8] 刘幸海 XingHai Liu. Progress in KARI and its Inhibitors [J]. Progress in Chemistry, 2008, 20(11): 1788-1797.
[9] Han Chunyan|Li Yan|Liu Gang**

. Drug-likeness: Predication and Practice [J]. Progress in Chemistry, 2008, 20(09): 1335-1344.
[10] Zhang Na1,Jiang Yongjun2**|Yu Qingsen1,Zou Jianwei2. Studies of Glycogen Synthase Kinase-3 Inhibitors [J]. Progress in Chemistry, 2007, 19(04): 614-623.
[11] Guizhao Liang1,Hu Mei1,Yuan Zhou1,Zhiliang Li 1,2*. Modeling Techniques of Multidimensional Quantitative Structure-Activity Relationship in Computer-Aided Drug Design [J]. Progress in Chemistry, 2006, 18(01): 120-130.
[12] Lu Weishen1,Zhang Xiaoru2**. The Bioactivity of Glycocluster and Glycodendrimer [J]. Progress in Chemistry, 2005, 17(06): 1054-1059.
[13] Hou Tingjun,Xu Xiaojie*. Applications of Genetic Algorithms to Computer-Aided Drug Design [J]. Progress in Chemistry, 2004, 16(01): 35-.
[14] Zhao Weiguang,Li Zhengming**,Wang Baolei,Wang Jianguo. High-Throughout Protein Crystallization and Its Application to Drug Design* [J]. Progress in Chemistry, 2004, 16(01): 105-.
[15] Wang Baolei,Li Zhengming*,Cang Hongjun. Influence of Genomics on Structure-based Drug Design [J]. Progress in Chemistry, 2003, 15(06): 505-.